Regencell Bioscience Holdings Limited (RGC)

RGC Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	2.36	2.42	2.96	1.56	6.42	0.06
Short-Term Investments	-	2.48	5	10	10	-
Cash & Short-Term Investments	2.36	4.9	7.96	11.56	16.42	0.06
Cash Growth	-	-38.49%	-31.16%	-29.56%	27532.00%	-84.65%
Other Current Assets	-	0.01	0.15	0.06	0.03	0.01
Total Current Assets	2.36	4.9	8.11	11.62	16.44	0.07
Net Property, Plant & Equipment	0.56	0.76	0.23	0.89	1.46	0.08
Other Long-Term Assets	0.09	0.09	0.1	0.11	0.11	0.19
Total Assets	3.01	5.76	8.44	12.62	18.02	0.34
Accrued Expenses	1.41	0.35	0.13	0.16	0.15	0.57
Short-Term Debt	-	-	-	-	-	3.68
Current Portion of Leases	0.26	0.31	0.06	0.44	0.41	-
Other Current Liabilities	0	0	0.01	0.01	0.02	0.08
Total Current Liabilities	1.67	0.66	0.19	0.61	0.58	4.34
Long-Term Leases	0.13	0.23	0.03	0.03	0.36	-
Total Long-Term Liabilities	0.13	0.23	0.03	0.03	0.36	-
Total Liabilities	1.79	0.9	0.22	0.63	0.94	4.34
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	31.76	30.12	29.88	29.43	28.51	0
Accumulated Other Comprehensive Income	-0.02	-0.06	-0.05	-0.09	-	-
Retained Earnings	-30.52	-25.2	-21.62	-17.32	-11.44	-4
Total Common Shareholders' Equity	1.22	4.86	8.22	12.03	17.07	-4
Minority Interest	-	-	-	-0.04	0.02	-
Shareholders' Equity	1.22	4.86	8.22	11.99	17.08	-4
Total Liabilities & Equity	3.01	5.76	8.44	12.62	18.02	0.34
Total Debt	0.39	0.54	0.09	0.46	0.77	3.68
Net Cash (Debt)	1.97	4.35	7.88	11.1	15.65	-3.62
Net Cash Growth	-54.72%	-44.73%	-29.06%	-29.05%	-	-
Net Cash Per Share	0.00	0.01	0.02	0.02	0.03	-0.01
Book Value	1.22	4.86	8.22	12.03	17.07	-4
Book Value Per Share	0.00	0.01	0.02	0.02	0.04	-0.01
Tangible Book Value	1.22	4.86	8.22	12.03	17.07	-4
Tangible Book Value Per Share	0.00	0.01	0.02	0.02	0.04	-0.01

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q